Impel NeuroPharma To Raise $45M Via Equity Offering
Impel NeuroPharma, fresh off IPO, gets FDA approval for nasal spray that treats migraines
Cowen Beefs Up Target Price For This Medical Device Firm
IMPL Stock: Over 10% Increase Explanation
FDA Gives Nod To Nasal Spray Migraine Treatment From Impel NeuroPharma; Stock Jumps
Impel Neuropharma raises $80M in Washington state's first IPO of 2021